Cited by 18Malaria Research and ControlMathematical and Theoretical Epidemiology and Ecology ModelsCOVID-19 epidemiological studies

Intermittent Preventive Treatment (IPT): Its Role in Averting Disease-Induced Mortality in Children and in Promoting the Spread of Antimalarial Drug Resistance

Open access
Manore, Carrie A., Teboh-Ewungkem, Miranda I., Prosper, Olivia, Peace, Angela, Gurski, Katharine, Feng, Zhilan·2019·Bulletin of Mathematical Biology

Abstract

We develop an age-structured ODE model to investigate the role of intermittent preventive treatment (IPT) in averting malaria-induced mortality in children, and its related cost in promoting the spread of antimalarial drug resistance. IPT, a malaria control strategy in which a full curative dose of an antimalarial medication is administered to vulnerable asymptomatic individuals at specified intervals, has been shown to reduce malaria transmission and deaths in children and pregnant women. However, it can also promote drug resistance spread. Our mathematical model is used to explore IPT effects on drug resistance and deaths averted in holoendemic malaria regions. The model includes drug-sensitive and drug-resistant strains as well as human hosts and mosquitoes. The basic reproduction, and invasion reproduction numbers for both strains are derived. Numerical simulations show the individual and combined effects of IPT and treatment of symptomatic infections on the prevalence of both strains and the number of lives saved. Our results suggest that while IPT can indeed save lives, particularly in high transmission regions, certain combinations of drugs used for IPT and to treat symptomatic infection may result in more deaths when resistant parasite strains are circulating. Moreover, the half-lives of the treatment and IPT drugs used play an important role in the extent to which IPT may influence spread of the resistant strain. A sensitivity analysis indicates the model outcomes are most sensitive to the reduction factor of transmission for the resistant strain, rate of immunity loss, and the natural clearance rate of sensitive infections.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11538-018-0524-1

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some countries are exploring alternative drugs or combination therapies for IPT.

    “However, some countries are now exploring alternative drugs or combination therapies for IPT [209–211].”

    From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [211]

    The Introduction (page unavailable) reports that a combination drug, sulfadoxine–pyrimethamine plus amodiaquine, has been used for IPT in infants and children. The Discussion and Conclusion (page unavailable) suggests considering additional IPT drugs, but does not say that countries are now exploring alternatives or combination therapies. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • In areas of high seasonal malaria transmission, seasonal malaria chemoprevention with a combination of mefloquine, or amodiaquine and SP is being used as a strategy to reduce the incidence of malaria in pregnancy.

    “To support this, in areas of high seasonal malaria transmission, seasonal malaria chemoprevention with a combination of mefloquine, or amodiaquine and SP is being used as a strategy to reduce the incidence of malaria in pregnancy [206, 211–213].”

    From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [211]

    The Introduction says preventive treatment with SP reduces malaria incidence in pregnant women, but describes SP plus amodiaquine for infants and children, not pregnancy; it does not describe mefloquine for this purpose. The Discussion and Conclusion says the paper considers year-round transmission and leaves seasonal transmission for future work. Thus, the pregnancy-prevention point is supported, but the specified drugs and seasonal setting are not. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Manore, C. A., Teboh-Ewungkem, M. I., Prosper, O., Peace, A., Gurski, K., & Feng, Z.
Affiliations
  • Los Alamos National Laboratory (US)
  • Lehigh University (US)
  • University of Kentucky (US)
  • Texas Tech University (US)
  • Howard University (US)
  • Purdue University West Lafayette (US)
Corresponding author
Manore, Carrie A.
Venue
Bulletin of Mathematical Biology
Published
2018-10-31
Volume
81
Issue
1
Pages
193-234
ISSN
  • 0092-8240 (ISSN-L)
  • 1522-9602
OpenAlex
W2581043098
Cited by
18
References
44
Citations by year
2026: 3 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 1 · 2020: 5
FWCI
1.19
Type
journal article
Language
en
Open access
Locations
  • Bulletin of Mathematical Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
  • ThinkTech (Texas Tech University) (submittedVersion, cc-by)
Funders
  • National Science Foundation (1361209)
  • Directorate for Mathematical and Physical Sciences (1314029)
  • American Institute of Mathematics (SquAREs)
  • Simons Foundation (245237)
  • Los Alamos National Laboratory (Director’s Postdoctoral Fellowship)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mathematical and Theoretical Epidemiology and Ecology Models
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords
intermittent preventive treatment, malaria, antimalarial drug resistance, child mortality, holoendemic malaria, basic reproduction number, asymptomatic malaria, transmission reduction, loss of immunity, malaria control
MeSH terms
Mosquito Vectors, Antimalarials, Child, Computer Simulation, Drug Administration Schedule, Drug Combinations, Drug Resistance, Female, Humans, Male, Models, Biological, Plasmodium falciparum, Pregnancy, Pyrimethamine, Sulfadoxine, Pregnancy Complications, Parasitic, Malaria, Falciparum, Basic Reproduction Number, Mathematical Concepts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review